SQLライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (14 11月 2023 @ 05:56):

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies...

Stats
本日の出来高	19 345.00
平均出来高	83 648.00
時価総額	2.51M
EPS	$-3.20 ( 2023-11-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.402
ATR14	$1.548 (29.49%)

Insider Trading

Date	Person	Action	Amount	type
2022-08-17	Pfeffer David	Buy	16 332	Common Stock
2022-08-17	Milos Patrice M.	Buy	8 800	Common Stock
2022-12-09	Jones Daniel Robert	Buy	5 733	Common Stock
2022-12-19	Miscoll Douglas Patrick	Buy	1 500	Common Stock
2022-12-19	Miscoll Douglas Patrick	Buy	1 500	Common Stock

INSIDER POWER
100.00
Last 31 transactions
Buy: 740 419 \| Sell: 110 811

ボリューム相関

長: 0.16 (neutral)

短: 0.49 (neutral)

Signal:(39.429) Neutral

SeqLL Inc. 相関

10 最も正の相関
RMRM	0.899
TDAC	0.871
GAINL	0.863
PAIC	0.859
NTEC	0.853
SVOK	0.849
MSGM	0.841
TLGT	0.837
NVFY	0.834
SVAC	0.831

10 最も負の相関
BOCH	-0.902
SHSP	-0.9
NETE	-0.898
MMAC	-0.86
DSPG	-0.842

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

SeqLL Inc. 相関 - 通貨/商品

-0.27
( neutral )

-0.77
( moderate negative )

-0.37
( neutral )

-0.56
( weak negative )

0.15
( neutral )

0.27
( neutral )

SeqLL Inc. 財務諸表

Annual	2022
収益:	$1 177.00
総利益:	$487.00 (41.38 %)
EPS:	$-14.11

FY	2022
収益:	$1 177.00
総利益:	$487.00 (41.38 %)
EPS:	$-14.11

FY	2021
収益:	$209 995
総利益:	$152 305 (72.53 %)
EPS:	$-0.317

FY	2020
収益:	$50 588.00
総利益:	$-120 215 (-237.64 %)
EPS:	$-0.0890

Financial Reports:

No articles found.

SeqLL Inc.

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.